In the ramp up to its stock hitting the market, the Mountain View-based chronic disease management company is hoping that investors value its Silicon Valley-infused user experience when it comes to health care, too.
In the ramp up to its stock hitting the market, the Mountain View-based chronic disease management company is hoping that investors value its Silicon Valley-infused user experience when it comes to health care, too.
